In this video, Dr. Brian Schwartz highlights several small-molecule TKIs in development with the potential to help patients with several malignancies.
Brian Schwartz, MD
Advertisement
Articles by Brian Schwartz, MD
Advertisement
Latest Updated Articles
Small-Molecule TKIs: Potential Benefit in Multiple MalignanciesPublished: April 26th 2018 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Durvalumab Plus Concurrent CRT Does Not Add Benefit in Stage III NSCLC
2
Radiotherapy Plus Chemoimmunotherapy Improves Frontline ES-SCLC Prognosis
3
Novel SSTR-Targeted Alpha Therapy Shows “Encouraging” Activity in GEP-NETs
4
Matched donor allogeneic CAR T for adult B-ALL: toxicity, efficacy, repeat dosing, and the importance of lymphodepletion
5
